Sitravatinib potentiates immune checkpoint blockade in refractory cancer models
Wenting Du(Sun Yat-sen University), Rolf A. Brekken(Southwestern Medical Center)
Cited by 111
Related Papers
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution
|JCI Insight|2019|281
Phosphorylation of Akt and ERK1/2 Is Required for VEGF-A/VEGFR2-Induced Proliferation and Migration of Lymphatic Endothelium
|PLoS ONE|2011|99
Targeting TGFβR2‐mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer
|EMBO Molecular Medicine|2019|87